Table 5.10b

Unadjusted Graft Survival, Deceased Donor ECD Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

		3 Months			1 Year			5 Years			10 Years
		(Tx 2005 - 2006)			(Tx 2005 - 2006)			(Tx 2001 - 2006)			(Tx 1996 - 2006)
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	3,483	92.3%	0.5%	3,483	84.6%	0.6%	8,907	55.3%	0.8%	14,721	28.0%	0.7%
Transplant Center State	ALABAMA	38	89.5%	5.0%	38	89.5%	5.0%	112	52.2%	5.9%	248	22.2%	5.0%
	ARKANSAS	29	93.1%	4.7%	29	86.2%	6.4%	50	56.2%	10.4%	69	25.4%	11.7%
	ARIZONA	34	88.2%	5.5%	34	82.4%	6.5%	92	69.2%	6.9%	139	43.5%	8.0%
	CALIFORNIA	332	94.3%	1.3%	332	87.7%	1.8%	1,034	58.3%	2.3%	1,724	32.7%	2.0%
	COLORADO	19	94.7%	5.1%	19	89.5%	7.0%	60	70.1%	9.6%	92	26.4%	10.6%
	CONNECTICUT	27	100.0%	0.0%	27	92.6%	5.0%	64	64.1%	7.0%	101	31.5%	7.7%
	FLORIDA	215	91.2%	1.9%	215	83.3%	2.5%	481	57.6%	3.3%	794	27.8%	2.7%
	GEORGIA	68	89.7%	3.7%	68	83.8%	4.5%	193	60.0%	4.3%	290	36.8%	4.8%
	HAWAII	24	100.0%	0.0%	24	100.0%	0.0%	53	70.8%	8.4%	92	45.5%	9.4%
	IOWA	20	95.0%	4.9%	20	89.7%	6.9%	48	63.6%	10.1%	91	24.8%	6.9%
	ILLINOIS	144	92.4%	2.2%	144	79.1%	3.4%	415	55.8%	3.7%	654	26.1%	3.3%
	INDIANA	31	96.8%	3.2%	31	93.5%	4.4%	77	60.1%	10.9%	110	42.1%	13.8%
	KANSAS	5	100.0%	0.0%	5	80.0%	17.9%	15	40.0%	29.1%	23	34.9%	17.3%
	KENTUCKY	17	100.0%	0.0%	17	100.0%	0.0%	80	49.9%	7.1%	142	29.7%	6.9%
	LOUISIANA	56	87.5%	4.4%	56	85.6%	4.7%	127	52.9%	7.2%	184	33.2%	5.8%
	MASSACHUSETTS	114	93.9%	2.2%	114	88.5%	3.0%	248	54.4%	5.2%	377	28.0%	4.7%
	MARYLAND	105	94.3%	2.3%	105	83.7%	3.6%	377	47.7%	3.4%	690	23.0%	3.0%
	MAINE	4	100.0%	0.0%	4	100.0%	0.0%	21	62.9%	11.5%	38	+	+
	MICHIGAN	95	92.6%	2.7%	95	85.3%	3.6%	230	57.5%	4.5%	357	31.5%	3.9%
	MINNESOTA	44	93.2%	3.8%	44	90.9%	4.3%	101	54.7%	8.8%	253	19.8%	4.7%
	MISSOURI	51	90.2%	4.2%	51	82.3%	5.4%	86	51.3%	10.6%	182	25.3%	4.6%
	MISSISSIPPI	0	-	-	0	-	-	2	50.0%	35.4%	18	22.2%	10.5%
	NORTH CAROLINA	104	94.2%	2.3%	104	88.5%	3.1%	248	65.8%	4.1%	420	26.0%	4.4%
	NORTH DAKOTA	12	75.0%	12.5%	12	66.7%	13.6%	44	40.5%	8.7%	65	27.5%	8.8%
	NEBRASKA	20	85.0%	8.0%	20	75.0%	9.7%	49	72.3%	7.0%	76	38.7%	9.7%
	NEW HAMPSHIRE	15	100.0%	0.0%	15	93.3%	6.4%	26	52.2%	13.9%	32	34.7%	16.5%
	NEW JERSEY	131	84.7%	3.1%	131	77.9%	3.6%	360	49.7%	3.8%	564	30.5%	3.2%
	NEW MEXICO	17	94.1%	5.7%	17	94.1%	5.7%	31	57.8%	15.5%	59	28.1%	9.6%
	NEVADA	2	100.0%	0.0%	2	100.0%	0.0%	18	43.3%	17.0%	36	19.5%	9.4%
	NEW YORK	420	90.5%	1.4%	420	81.6%	1.9%	857	50.8%	2.6%	1,361	28.7%	2.1%
	OHIO	149	87.9%	2.7%	149	78.4%	3.4%	340	53.4%	3.9%	621	28.2%	2.9%
	OKLAHOMA	27	92.6%	5.0%	27	77.6%	8.1%	74	58.7%	6.6%	119	29.7%	7.2%
	OREGON	30	96.7%	3.3%	30	93.3%	4.6%	135	65.0%	5.0%	198	48.7%	6.4%
	PENNSYLVANIA	362	90.9%	1.5%	362	83.6%	2.0%	939	48.5%	2.3%	1,530	23.2%	2.1%
	PUERTO RICO	21	100.0%	0.0%	21	95.2%	4.6%	37	78.6%	8.5%	50	0.0%	0.0%
	RHODE ISLAND	9	100.0%	0.0%	9	100.0%	0.0%	44	50.4%	8.9%	63	14.9%	12.4%
	SOUTH CAROLINA	21	100.0%	0.0%	21	95.2%	4.6%	57	33.4%	11.5%	98	18.0%	6.0%
	SOUTH DAKOTA	24	91.7%	5.6%	24	79.2%	8.3%	59	49.2%	10.4%	77	17.6%	8.5%
	TENNESSEE	66	95.5%	2.6%	66	89.3%	3.8%	177	56.9%	5.1%	295	18.4%	4.1%
	TEXAS	220	91.4%	1.9%	220	82.7%	2.6%	566	56.0%	3.5%	898	32.3%	2.9%
	UTAH	8	87.5%	11.7%	8	87.5%	11.7%	20	67.6%	12.3%	41	35.9%	10.1%
	VIRGINIA	115	97.4%	1.5%	115	93.0%	2.4%	257	60.3%	4.6%	377	26.4%	4.2%
	VERMONT	13	92.3%	7.4%	13	92.3%	7.4%	21	90.5%	6.4%	30	31.0%	23.2%
	WASHINGTON	49	98.0%	2.0%	49	83.6%	5.3%	128	64.5%	5.6%	279	32.3%	4.4%
	WISCONSIN	126	96.0%	1.7%	126	83.3%	3.3%	353	51.3%	3.9%	542	28.6%	3.8%
	WEST VIRGINIA	6	100.0%	0.0%	6	83.3%	15.2%	23	69.4%	12.3%	70	15.7%	7.4%

Source: OPTN/SRTR Data as of May 1, 2008.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Dialysis needed within first week excludes patients whose graft failed before the end of the week.